SlideShare a Scribd company logo
1 of 82
Uremic Pruritus
Pathogenesis & Management
Mohammed Abdel Gawad
Nephrology Specialist
Kidney & Urology Center (KUC)
Alexandria – EGY
drgawad@gmail.com
7th NephroShams / 15-17 Oct 2015
Weak Soft Evidence
• Small number of patients were tested by
different studies.
• Conflicting and contradictory results
• Short time of follow up
• Lack of head-to-head comparisons among
different agents
19
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
19
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
19
Hiroshige K. Am J Kidney Dis. 1995 Mar;25(3):413-9.
3 months of
observation
n=59
19
n=111
Ko MJ et al. PLoS One. 2013 Aug 6;8(8):e71404.
p = 0.002
18
Saudi J Kidney Dis Transpl 2015;26(5):890-895
Significantly higher Kt/V in the patients with pruritus.
18
n=105
Duque MI et al. Clin Nephrol 2006; 66:184.
18
n=105
• Higher Kt/V = prolonged contact with dialyzer membranes or
silicone tubing.
• If no residual renal function or worse metabolic parameters =
need higher Kt/V
Accounted for the pruritus
Duque MI et al. Clin Nephrol 2006; 66:184.
18
It is suggested to use generally accepted Kt/V
targets because of overall benefit conferred
rather than a specific demonstrated effect on
pruritus
17
Ko MJ et al. PLoS One. 2013 Aug 6;8(8):e71404.
17
Lin HH et al. Artif Organs. 2008 Jun;32(6):468-72.
Started using PMMA
P < 0.001
Back to previously
used high flux filter
17
Lin HH et al. Artif Organs. 2008 Jun;32(6):468-72.
Started using PMMA
Back to previously
used high flux filter
P < 0.001
17
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
16
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
16
Pathogenesis
Xerosis
Decrease in
sweat volume Atrophy
Dehydration
Pornanong Aramwit. Updates in Hemodialysis. Chapter 2. September 9, 2015.
16
Topical Moisturing & Emollients
Thomas Mettang. Kidney International (2015) 87, 685–691.
Manenti et al. Kidney Int, 2008. 73(4): p. 512.
It has been suggested by several researchers
that the use of emollients with high water
content should be the first-line treatment
• Dexpanthenol
• Glycerol and Paraffin
• If simple emollients fail:
–Evening Primrose oil rich in essential fatty
acids (γ-linolenic acid)
–Bath oil that contains polidocanol
–Cream that contains natural lipids and
endocannabinoids
Pornanong Aramwit. Updates in Hemodialysis. Chapter 2. September 9, 2015.
16
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
15
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
15
Pathogenesis – Microinflamation (1)
Interleukin 2
Th1 lymphocytes
Interleukin 2
Kurban et al. Clin Dermatol, 2008. 26(3): p. 255-264.
15
Th1 lymphocytes
Interleukin 2
Gianni LM et al. Ann Pharmacother 2001; 35: 943–946.
Pauli-Magnus C et al. Perit Dial Int 2000; 6: 802–803.
Kuypers DR et al. Nephrol Dial Transplant 2004; 19: 1895–1901.
Tacrolimus Ointment
2 times/day for 1-6 weeks
15
Th1 lymphocytes
Interleukin 2
Gianni LM et al. Ann Pharmacother 2001; 35: 943–946.
Pauli-Magnus C et al. Perit Dial Int 2000; 6: 802–803.
Kuypers DR et al. Nephrol Dial Transplant 2004; 19: 1895–1901.
Tacrolimus Ointment
2 times/day for 1-6 weeks
15
Pathogenesis – Microinflamation (2)
TNF-α and IL-1β
Aramwit et al. J Biosci Bioeng, 2009. 107(5): p. 556-561.
14
Sericin Cream (concentration 8%)
Water-soluble protein that is obtained from
the silkworm (Bombyx mori)
Characterized by the presence of
32% serine, which is the main
amino acid of the natural moisture
factor (NMF) in human skin
Pornanong Aramwit. Updates in Hemodialysis. Chapter 2. September 9, 2015.
O. Keongamaroon. et al. BMC Nephrol, 2012. 13: p. 119.
Twice daily for 6 weeks
14
Sericin Cream (concentration 8%)
Water-soluble protein that is obtained from
the silkworm (Bombyx mori)
Pornanong Aramwit. Updates in Hemodialysis. Chapter 2. September 9, 2015.
O. Keongamaroon. et al. BMC Nephrol, 2012. 13: p. 119.
Twice daily for 6 weeks
14
Pathogenesis – Microinflamation (3)
TNF-α
Zhang R et al. J Immunother 2007; 30: 89–95
Silva SR et al. Nephron 1994; 67: 270–273.
TNF α
Thalidomide
Pentoxifylline
14
Pentoxifylline - Pathogenesis
The American Journal of Gastroenterology 109, 1424-1426 (September 2014)
Anti-inflammatory
13
Mettang T et al. Nephrol Dial Transplant 2007; 22: 2727–2728.
Pentoxifylline: 600mg IV,
3X/week (at the end of each
dialysis session), for 4 weeks
n = 7 on HD (didn’t respond to
gabapentin or UVB-phototherapy)
3 patients
stopped
treatment
n = 1 Insomnia
n = 2 Nausea
n = 1 Jaundice
Itch score (median; range)
13
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
10
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
13
Pathogenesis – Nervous Conduction (1)
Substance P
C fibers
Tarikci N et al. Scientific World Journal. 2015;2015:803752
Kuypers DR. Nat Clin Pract Nephrol 2009; 5:157.
12
Capsaicin 0.025% Cream
C fibers
Tarng, D.C. et al. Nephron, 1996. 72(4): p. 617-622.
Breneman et al. J Am Acad Dermatol, 1992. 26(1): p. 91-94.
Cho YL et al. J Am Acad Dermatol 1997; 36:538.
Kuypers DR. Nat Clin Pract Nephrol 2009; 5:157.
Extract from capsicum or common pepper plant
12
Capsaicin 0.025% Cream
C fibers
Tarng, D.C. et al. Nephron, 1996. 72(4): p. 617-622.
Breneman et al. J Am Acad Dermatol, 1992. 26(1): p. 91-94.
Cho YL et al. J Am Acad Dermatol 1997; 36:538.
Kuypers DR. Nat Clin Pract Nephrol 2009; 5:157.
Extract from capsicum or common pepper plant
12
vanilloid
receptor
subtype 1
Capsaicin 0.025% Cream
C fibers
Tarng, D.C. et al. Nephron, 1996. 72(4): p. 617-622.
Breneman et al. J Am Acad Dermatol, 1992. 26(1): p. 91-94.
Cho YL et al. J Am Acad Dermatol 1997; 36:538.
Kuypers DR. Nat Clin Pract Nephrol 2009; 5:157.
Extract from capsicum or common pepper plant
12
vanilloid
receptor
subtype 1
May not be a practical solution for
large areas or generalized pruritus
Pathogenesis – Nervous Conduction (2)
Ca Channel
Thomas Mettang. Kidney International (2015) 87, 685–691.
12
Gabapentin / Pregabalin
Thomas Mettang. Kidney International (2015) 87, 685–691.
11
Razeghi E et al. Ren Fail 2009; 31: 85–90.
Gabapentin
n = 34 on HD
Double-blind,
Crossover study
100 mg of oral
gabapentin
3X/week
Gabapentin
therapy
phase
Washout &
Placebo
phase
11
Gunal AI et al. Nephrol Dial Transplant 2004; 19: 3137–3139.
n = 25 on HD
300 mg of oral
gabapentin
3X/week
for 4 weeks
8.4
1.2
4 weeks
Gabapentin 11
Gunal AI et al. Nephrol Dial Transplant 2004; 19: 3137–3139.
Pregabalin
21
10
Gunal AI et al. Nephrol Dial Transplant 2004; 19: 3137–3139.
Pregabalin
16 started Pregabalin
21
n = 13
(81%)
10
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
10
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
10
Pathogenesis
Opioid Hypothesis
Keiichi Niikura et al. Trends in Pharm Science. Volume 31, Issue 7. July 2010, Pages 299–305
10
Pain
↓ Pain
Ƙ opioid receptor
µ opioid receptor
Pathogenesis
Opioid Hypothesis
Kumagai H et al. In: Itch, Basic Mechanisms and Therapy, New York 2004. p.286.
9
Pain
↓ Pain
Ratio of the µ-
receptor agonist
(beta-endorphin)
to
Ƙ-receptor agonist
(dynorphin-A)
is increased in
hemodialysis
patients
µ opioid receptor
Ƙ opioid receptor
Naltrexone / Nalfurafine
Kumagai H et al. In: Itch, Basic Mechanisms and Therapy, New York 2004. p.286.
9
Pain
↓ Pain
µ opioid receptor
Ƙ opioid receptor
Naltrexone
µ-antagonist
Nalfurafine
Ƙ-agonist
Naltrexone (µ-antagonist)
Peer G et al. Lancet 1996; 348: 1552–1554.14.
n = 15
9
Kumagai H et al. Nephrol Dial Transplant 2010; 25: 1251–1257.
Nalfurafine (Ƙ-agonist)
Placebo (n=111)
5 µg (n=144), P = 0.0002
2.5 µg (n=112), P = 0.0001
8
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
8
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
8
Felix Stockenhuber et al. Clinical Science (1990) 79,477-482
8
Weisshaar E et al. Exp Dermatol 2004; 13: 298–304.
7
Weisshaar E et al. Exp Dermatol 2004; 13: 298–304.
Beneficial effect of anti-
histamincs probably results
from their sleep-inducing side
effect
7
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-recptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
7
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-recptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
7
PTH
• Persistent uremic pruritus of patients with
secondary hyperparathyroidism decreased after
parathyroidectomy
• Intradermal application of parathormone did not
cause a significant skin reaction in humans.
• Itching can occur in patients with accepted PTH
serum level.
Kleeman CR et al. Trans Assoc Am Physicians. 1968;81:203–212.
Massry SG et al. N Engl J Med. 1968;279(13):697–700.
Ståhle-Bäckdahl M et al. J Intern Med. 1989;225(6):411–415.
7
Calcium & Phosphorous
• Hypercalcemia and hyperphosphatemia with
secondary deposition of calcium phosphate crystals
in the skin may contribute to itch.
• Calcium × phosphate < 55 can play a role in
improving the pruritus.
• Pruritus may recur when serum calcium is restored
to normal, or persist despite low serum calcium
levels.
Kurban et al. . Clin Dermatol, 2008. 26(3): p. 255-264.
Schwartz, I.F. and A. Iaina, Semin Dial, 2000. 13(3): p. 177-180.
6
Chou FF et al. J Am Coll Surg 2000; 190:65.
6
Chou FF et al. J Am Coll Surg 2000; 190:65.
6
Chou FF et al. J Am Coll Surg 2000; 190:65.
5
• Parathyroidectomy should not be considered
as a routine therapy for uremic pruritus.
• Target the commonly accepted calcium,
phosphate and PTH concentrations that have
been developed for the overall benefit of
such patients.
5
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
5
PHOTOTHERAPY
UVB vs. UVA
• Broad band UVB phototherapy reported a
marked reduction in pruritus.
• Long-wave UVA radiation treatment did not
improve itch intensity.
• Saltzer et al. Cutis, 1975. 16: p.298-299.
• Gilchrest et al. N Engl J Med, 1977. 297(3): p. 136-138
• Gilchrest et al. Ann Intern Med 1979; 91: 17–21.
• Gilchrest. Int J Dermatol, 1979. 18(9): p. 741-748.
• Blachley et al. Am J Kidney Dis, 1985. 5(5): p.237-241.
• Tan JKL et al. J Amer Acad Dermatol 1991; 25: 811–818.
• Kurban et al. Clin Dermatol, 2008. 26(3): p. 255-264.
4
International Journal of Dermatology. 2007, 46, 367–370
n = 15
5.5  2.7
12  4.1
4
M-J. Ko et al. Briish Association of Dermatologists 2011 165, pp633–639
The treatment group received NB-UVB phototherapy
three times per week for 6 weeks.
The control group received time-matched exposures to
long-wave UVA radiation.
4
PHOTOTHERAPY
High risk for skin malignancies
following UVB irradiation
Thomas Mettang. Kidney International (2015) 87, 685–691.
Other Physical Therapies
• Acupuncture
• Thermal Therapy
• Sauna
3
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
3
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
3
OTHERS
• Sertraline
• Activated charcoal
• Erythropoietin
• Omega-3 fatty acid
• Turmeric
• Zinc
• Cholestyramine
• Avena sativa
• Vinegar
• Oral nicotinamide
• Pramoxine ointement
• IV Lidocaine
3
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
2
Thomas Mettang. Kidney International (2015) 87, 685–691.
2
Thomas Mettang. Kidney International (2015) 87, 685–691.
2
More accurately to be termed
‘chronic kidney disease-associated
pruritus’
(CKD-aP)
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
2
1
Thomas Mettang. Kidney International (2015) 87, 685–691.
Thomas Mettang. Kidney International (2015) 87, 685–691.
Modification: M.Gawad www.NephroTubeCNE.com
Control Ca, Phosphrous, PTH
Pregabalin
(25mg after HD
to 75 mg daily)
if not well
tolerated or
no response
(50 mg daily) !!! Skin cancer
1
Modified approach
according to available
drugs in Egypt and
adding of another
drugs with re-
arrangement of the
drugs sequence
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
1
Talk Outline
• Dialysis adequacy & modification
• Xerosis
• Microinflamation
• Nervous conduction
• Opioid hypothesis
• Anti-histamine / 5HT3-receptor antagonist
• PTH / Calcium / Phosphorus
• Physical therapy (UV)
• Other therapies
• Terminology
• Suggested step wise management approach
• Is it uremic pruritus?
1
Is it uremic pruritus?
• Site: most commonly localized to the back,
followed by the forearm with an AVF,
abdomen, or head.
• Most cases presents dry and scaly.
• In contrast to dermatological pruritus, primary
skin lesions are not observed in patients with
CKD-aP.
Thomas Mettang. Kidney International (2015) 87, 685–691.
0
Is it uremic pruritus?
• Site: most commonly localized to the back,
followed by the forearm with an AVF,
abdomen, or head.
• Most cases presents dry and scaly.
• In contrast to dermatological pruritus, primary
skin lesions are not observed in patients with
CKD-aP.
Thomas Mettang. Kidney International (2015) 87, 685–691.
Scratch marks with
excoriations
Hyperkeratotic partly
excoriated nodules
(prurigo nodularis)
Deep scars and prurigo
nodules
0
Is it uremic pruritus?
Thomas Mettang. Kidney International (2015) 87, 685–691.
• Suspect other etiology if:
–More generalized.
–Primary specific skin lesions.
–Resistant pruritus.
Acta Derm Venereol 2012; 92: 563–581
0
Thomas Mettang. Kidney International (2015) 87, 685–691.
Modification: M.Gawad www.NephroTubeCNE.com
Control Ca, Phosphrous, PTH
Pregabalin
(25mg after HD
to 75 mg daily)
if not well
tolerated or
no response
(50 mg daily) !!! Skin cancer
Exclusion of
other
causes
including
drugs if
resistant
0
Modified approach
according to available
drugs in Egypt and
adding of another
drugs with re-
arrangement of the
drugs sequence
Thomas Mettang. Kidney International (2015) 87, 685–691.
Modification: M.Gawad www.NephroTubeCNE.com
Control Ca, Phosphrous, PTH
Pregabalin
(25mg after HD
to 75 mg daily)
if not well
tolerated or
no response
(50 mg daily) !!! Skin cancer
Exclusion of
other
causes
including
drugs if
resistant
0
Modified approach
according to available
drugs in Egypt and
adding of another
drugs with re-
arrangement of the
drugs sequence
Gawad
Thank You

More Related Content

What's hot

Hypokalemia (Practical Approach) - Dr. Gawad
Hypokalemia (Practical Approach) - Dr. GawadHypokalemia (Practical Approach) - Dr. Gawad
Hypokalemia (Practical Approach) - Dr. GawadNephroTube - Dr.Gawad
 
complications of HD case presentation
complications of HD case presentationcomplications of HD case presentation
complications of HD case presentationDr. Abrar Ali Katpar
 
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. GawadFocal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
 
Anemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. GawadAnemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. GawadNephroTube - Dr.Gawad
 
CKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. GawadCKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. GawadNephroTube - Dr.Gawad
 
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. GawadCKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. GawadNephroTube - Dr.Gawad
 
Ckd mbd where are we
Ckd mbd where are weCkd mbd where are we
Ckd mbd where are weFarragBahbah
 
Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
Electrolytes & Acid-Base Disturbance Workshop - Dr. GawadElectrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
Electrolytes & Acid-Base Disturbance Workshop - Dr. GawadNephroTube - Dr.Gawad
 
Hypernatremia (Practical Approach) - Dr. Gawad
Hypernatremia (Practical Approach) - Dr. GawadHypernatremia (Practical Approach) - Dr. Gawad
Hypernatremia (Practical Approach) - Dr. GawadNephroTube - Dr.Gawad
 
Uric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
Uric acid and CKD (Consequences, Management and Evidence) - Dr. GawadUric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
Uric acid and CKD (Consequences, Management and Evidence) - Dr. GawadNephroTube - Dr.Gawad
 
Hyperkalemia (Practical Approach) - Dr. Gawad
Hyperkalemia (Practical Approach) - Dr. GawadHyperkalemia (Practical Approach) - Dr. Gawad
Hyperkalemia (Practical Approach) - Dr. GawadNephroTube - Dr.Gawad
 
Hyperphosphatemia in CKD
Hyperphosphatemia in CKDHyperphosphatemia in CKD
Hyperphosphatemia in CKDRehab Rayan
 
ESAs Therapy: Friend or Foe? - Dr. Gawad
ESAs Therapy: Friend or Foe? - Dr. GawadESAs Therapy: Friend or Foe? - Dr. Gawad
ESAs Therapy: Friend or Foe? - Dr. GawadNephroTube - Dr.Gawad
 
Renal hyperparathyrodism
Renal hyperparathyrodismRenal hyperparathyrodism
Renal hyperparathyrodismFarragBahbah
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadNephroTube - Dr.Gawad
 
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad NephroTube - Dr.Gawad
 
Chronic Kidney Disease-Mineral Bone Disease
Chronic Kidney Disease-Mineral Bone DiseaseChronic Kidney Disease-Mineral Bone Disease
Chronic Kidney Disease-Mineral Bone DiseaseWaleed El-Refaey
 
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. GawadChallenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. GawadNephroTube - Dr.Gawad
 

What's hot (20)

Hypokalemia (Practical Approach) - Dr. Gawad
Hypokalemia (Practical Approach) - Dr. GawadHypokalemia (Practical Approach) - Dr. Gawad
Hypokalemia (Practical Approach) - Dr. Gawad
 
complications of HD case presentation
complications of HD case presentationcomplications of HD case presentation
complications of HD case presentation
 
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. GawadFocal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
 
Anemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. GawadAnemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. Gawad
 
CKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. GawadCKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. Gawad
 
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. GawadCKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
 
Ckd mbd where are we
Ckd mbd where are weCkd mbd where are we
Ckd mbd where are we
 
Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
Electrolytes & Acid-Base Disturbance Workshop - Dr. GawadElectrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
 
Hypernatremia (Practical Approach) - Dr. Gawad
Hypernatremia (Practical Approach) - Dr. GawadHypernatremia (Practical Approach) - Dr. Gawad
Hypernatremia (Practical Approach) - Dr. Gawad
 
Uric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
Uric acid and CKD (Consequences, Management and Evidence) - Dr. GawadUric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
Uric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
 
Hyperkalemia (Practical Approach) - Dr. Gawad
Hyperkalemia (Practical Approach) - Dr. GawadHyperkalemia (Practical Approach) - Dr. Gawad
Hyperkalemia (Practical Approach) - Dr. Gawad
 
Hyperphosphatemia in CKD
Hyperphosphatemia in CKDHyperphosphatemia in CKD
Hyperphosphatemia in CKD
 
ESAs Therapy: Friend or Foe? - Dr. Gawad
ESAs Therapy: Friend or Foe? - Dr. GawadESAs Therapy: Friend or Foe? - Dr. Gawad
ESAs Therapy: Friend or Foe? - Dr. Gawad
 
Renal hyperparathyrodism
Renal hyperparathyrodismRenal hyperparathyrodism
Renal hyperparathyrodism
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. Gawad
 
Esa
EsaEsa
Esa
 
CKD MBD 2017
CKD MBD 2017CKD MBD 2017
CKD MBD 2017
 
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
 
Chronic Kidney Disease-Mineral Bone Disease
Chronic Kidney Disease-Mineral Bone DiseaseChronic Kidney Disease-Mineral Bone Disease
Chronic Kidney Disease-Mineral Bone Disease
 
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. GawadChallenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
 

Viewers also liked

Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. GawadPregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. GawadNephroTube - Dr.Gawad
 
Uremic Pruritus (Basic Science → Evidence → Practice) - Dr. Gawad
Uremic Pruritus (Basic Science → Evidence → Practice) - Dr. GawadUremic Pruritus (Basic Science → Evidence → Practice) - Dr. Gawad
Uremic Pruritus (Basic Science → Evidence → Practice) - Dr. GawadNephroTube - Dr.Gawad
 
Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...
Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...
Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...NephroTube - Dr.Gawad
 
CKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. GawadCKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. GawadNephroTube - Dr.Gawad
 
Diabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. Gawad
Diabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. GawadDiabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. Gawad
Diabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. GawadNephroTube - Dr.Gawad
 
Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....
Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....
Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....NephroTube - Dr.Gawad
 
How to examine AVF in 10 minutes - Dr. Gawad
How to examine AVF in 10 minutes - Dr. GawadHow to examine AVF in 10 minutes - Dr. Gawad
How to examine AVF in 10 minutes - Dr. GawadNephroTube - Dr.Gawad
 
Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...
Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...
Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...NephroTube - Dr.Gawad
 
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...NephroTube - Dr.Gawad
 
Membranous Nephropathy - Management Algorithm - Dr. Gawad
Membranous Nephropathy - Management Algorithm - Dr. GawadMembranous Nephropathy - Management Algorithm - Dr. Gawad
Membranous Nephropathy - Management Algorithm - Dr. GawadNephroTube - Dr.Gawad
 
Hemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. Gawad
Hemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. GawadHemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. Gawad
Hemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. GawadNephroTube - Dr.Gawad
 
Hyponatremia (Into Practice) - Dr. Gawad
Hyponatremia  (Into Practice) - Dr. GawadHyponatremia  (Into Practice) - Dr. Gawad
Hyponatremia (Into Practice) - Dr. GawadNephroTube - Dr.Gawad
 

Viewers also liked (13)

Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. GawadPregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
 
Uremic Pruritus (Basic Science → Evidence → Practice) - Dr. Gawad
Uremic Pruritus (Basic Science → Evidence → Practice) - Dr. GawadUremic Pruritus (Basic Science → Evidence → Practice) - Dr. Gawad
Uremic Pruritus (Basic Science → Evidence → Practice) - Dr. Gawad
 
Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...
Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...
Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...
 
CKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. GawadCKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. Gawad
 
Diabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. Gawad
Diabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. GawadDiabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. Gawad
Diabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. Gawad
 
Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....
Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....
Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....
 
How to examine AVF in 10 minutes - Dr. Gawad
How to examine AVF in 10 minutes - Dr. GawadHow to examine AVF in 10 minutes - Dr. Gawad
How to examine AVF in 10 minutes - Dr. Gawad
 
Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...
Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...
Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...
 
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
 
CRRT in ICU - AKI - Dr. Gawad
CRRT in ICU - AKI - Dr. GawadCRRT in ICU - AKI - Dr. Gawad
CRRT in ICU - AKI - Dr. Gawad
 
Membranous Nephropathy - Management Algorithm - Dr. Gawad
Membranous Nephropathy - Management Algorithm - Dr. GawadMembranous Nephropathy - Management Algorithm - Dr. Gawad
Membranous Nephropathy - Management Algorithm - Dr. Gawad
 
Hemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. Gawad
Hemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. GawadHemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. Gawad
Hemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. Gawad
 
Hyponatremia (Into Practice) - Dr. Gawad
Hyponatremia  (Into Practice) - Dr. GawadHyponatremia  (Into Practice) - Dr. Gawad
Hyponatremia (Into Practice) - Dr. Gawad
 

Similar to Uremic Pruritis - Pathogenesis & Management - Dr. Gawad

Uremic Pruritus - A life annoying problem - Dr. Gawad
Uremic Pruritus - A life annoying problem - Dr. GawadUremic Pruritus - A life annoying problem - Dr. Gawad
Uremic Pruritus - A life annoying problem - Dr. GawadNephroTube - Dr.Gawad
 
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. GawadLupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. GawadNephroTube - Dr.Gawad
 
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...MNDU net
 
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ing
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ingSalon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ing
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ingtyfngnc
 
Homeostasis & Steroids - Dr. Shweta Yadav - Oral and Maxillofacial Surgery
Homeostasis & Steroids - Dr. Shweta Yadav - Oral and Maxillofacial SurgeryHomeostasis & Steroids - Dr. Shweta Yadav - Oral and Maxillofacial Surgery
Homeostasis & Steroids - Dr. Shweta Yadav - Oral and Maxillofacial SurgeryDr. Shweta Yadav
 
Prof.Amr El-Husseini Mohamed
Prof.Amr El-Husseini MohamedProf.Amr El-Husseini Mohamed
Prof.Amr El-Husseini MohamedFarragBahbah
 
Prof.Amr El Husseini Mohamed
Prof.Amr El Husseini MohamedProf.Amr El Husseini Mohamed
Prof.Amr El Husseini MohamedFarragBahbah
 
Asthma_Medication.pdf
Asthma_Medication.pdfAsthma_Medication.pdf
Asthma_Medication.pdfRutvikShah52
 
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...Hussain Karimi
 
Modified therapeutic plasma-exchange
Modified therapeutic plasma-exchangeModified therapeutic plasma-exchange
Modified therapeutic plasma-exchangeFarragBahbah
 
Homeostasis,cell physiology -- By Prof.Dr.R.R.Deshpande
Homeostasis,cell physiology  -- By Prof.Dr.R.R.DeshpandeHomeostasis,cell physiology  -- By Prof.Dr.R.R.Deshpande
Homeostasis,cell physiology -- By Prof.Dr.R.R.Deshpanderajendra deshpande
 
Immunosuppression immunomodulation
Immunosuppression immunomodulationImmunosuppression immunomodulation
Immunosuppression immunomodulationFarragBahbah
 
Hiperparathyroid and Kidney Stone
Hiperparathyroid and Kidney StoneHiperparathyroid and Kidney Stone
Hiperparathyroid and Kidney StoneEko indra
 
Iron chelation in Beta thalassemia
Iron chelation in Beta thalassemiaIron chelation in Beta thalassemia
Iron chelation in Beta thalassemiahasmukh balar
 
Recent Trends in Gerd Management
Recent Trends in Gerd ManagementRecent Trends in Gerd Management
Recent Trends in Gerd ManagementHossam Ghoneim
 
Evaluating the efficacy of different platelet rich plasma regimens for manage...
Evaluating the efficacy of different platelet rich plasma regimens for manage...Evaluating the efficacy of different platelet rich plasma regimens for manage...
Evaluating the efficacy of different platelet rich plasma regimens for manage...anestesiaudec
 
Organophosphate Poisoning - Update on Management
Organophosphate Poisoning  - Update on Management Organophosphate Poisoning  - Update on Management
Organophosphate Poisoning - Update on Management Anoop James
 
Management of organ donor following brain death 2016
Management of organ donor following brain death  2016Management of organ donor following brain death  2016
Management of organ donor following brain death 2016intentdoc
 
PAH Drug Discovery and Development: State of the Art in 2022
PAH Drug Discovery and Development: State of the Art in 2022PAH Drug Discovery and Development: State of the Art in 2022
PAH Drug Discovery and Development: State of the Art in 2022Duke Heart
 

Similar to Uremic Pruritis - Pathogenesis & Management - Dr. Gawad (20)

Uremic Pruritus - A life annoying problem - Dr. Gawad
Uremic Pruritus - A life annoying problem - Dr. GawadUremic Pruritus - A life annoying problem - Dr. Gawad
Uremic Pruritus - A life annoying problem - Dr. Gawad
 
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. GawadLupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
 
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...
 
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ing
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ingSalon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ing
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ing
 
Homeostasis & Steroids - Dr. Shweta Yadav - Oral and Maxillofacial Surgery
Homeostasis & Steroids - Dr. Shweta Yadav - Oral and Maxillofacial SurgeryHomeostasis & Steroids - Dr. Shweta Yadav - Oral and Maxillofacial Surgery
Homeostasis & Steroids - Dr. Shweta Yadav - Oral and Maxillofacial Surgery
 
Prof.Amr El-Husseini Mohamed
Prof.Amr El-Husseini MohamedProf.Amr El-Husseini Mohamed
Prof.Amr El-Husseini Mohamed
 
Prof.Amr El Husseini Mohamed
Prof.Amr El Husseini MohamedProf.Amr El Husseini Mohamed
Prof.Amr El Husseini Mohamed
 
Menopause
Menopause Menopause
Menopause
 
Asthma_Medication.pdf
Asthma_Medication.pdfAsthma_Medication.pdf
Asthma_Medication.pdf
 
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
 
Modified therapeutic plasma-exchange
Modified therapeutic plasma-exchangeModified therapeutic plasma-exchange
Modified therapeutic plasma-exchange
 
Homeostasis,cell physiology -- By Prof.Dr.R.R.Deshpande
Homeostasis,cell physiology  -- By Prof.Dr.R.R.DeshpandeHomeostasis,cell physiology  -- By Prof.Dr.R.R.Deshpande
Homeostasis,cell physiology -- By Prof.Dr.R.R.Deshpande
 
Immunosuppression immunomodulation
Immunosuppression immunomodulationImmunosuppression immunomodulation
Immunosuppression immunomodulation
 
Hiperparathyroid and Kidney Stone
Hiperparathyroid and Kidney StoneHiperparathyroid and Kidney Stone
Hiperparathyroid and Kidney Stone
 
Iron chelation in Beta thalassemia
Iron chelation in Beta thalassemiaIron chelation in Beta thalassemia
Iron chelation in Beta thalassemia
 
Recent Trends in Gerd Management
Recent Trends in Gerd ManagementRecent Trends in Gerd Management
Recent Trends in Gerd Management
 
Evaluating the efficacy of different platelet rich plasma regimens for manage...
Evaluating the efficacy of different platelet rich plasma regimens for manage...Evaluating the efficacy of different platelet rich plasma regimens for manage...
Evaluating the efficacy of different platelet rich plasma regimens for manage...
 
Organophosphate Poisoning - Update on Management
Organophosphate Poisoning  - Update on Management Organophosphate Poisoning  - Update on Management
Organophosphate Poisoning - Update on Management
 
Management of organ donor following brain death 2016
Management of organ donor following brain death  2016Management of organ donor following brain death  2016
Management of organ donor following brain death 2016
 
PAH Drug Discovery and Development: State of the Art in 2022
PAH Drug Discovery and Development: State of the Art in 2022PAH Drug Discovery and Development: State of the Art in 2022
PAH Drug Discovery and Development: State of the Art in 2022
 

More from NephroTube - Dr.Gawad

Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...NephroTube - Dr.Gawad
 
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. GawadObesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. GawadNephroTube - Dr.Gawad
 
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadThrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadNephroTube - Dr.Gawad
 
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. GawadAsymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. GawadNephroTube - Dr.Gawad
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
 
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. GawadLupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
 
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
 
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. GawadInfection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
 
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...NephroTube - Dr.Gawad
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
 
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)NephroTube - Dr.Gawad
 
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadInsights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadNephroTube - Dr.Gawad
 
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadDiabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadNephroTube - Dr.Gawad
 
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...NephroTube - Dr.Gawad
 
Hyponatremia (Practical Approach) - Dr. Gawad
Hyponatremia (Practical Approach) - Dr. GawadHyponatremia (Practical Approach) - Dr. Gawad
Hyponatremia (Practical Approach) - Dr. GawadNephroTube - Dr.Gawad
 
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...NephroTube - Dr.Gawad
 
Autosomal Dominant Polycystic Kidney Disease (ADPKD) / Emerging Concepts and ...
Autosomal Dominant Polycystic Kidney Disease (ADPKD) / Emerging Concepts and ...Autosomal Dominant Polycystic Kidney Disease (ADPKD) / Emerging Concepts and ...
Autosomal Dominant Polycystic Kidney Disease (ADPKD) / Emerging Concepts and ...NephroTube - Dr.Gawad
 
AVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. Gawad
AVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. GawadAVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. Gawad
AVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. GawadNephroTube - Dr.Gawad
 
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...NephroTube - Dr.Gawad
 

More from NephroTube - Dr.Gawad (20)

Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
 
Contrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. GawadContrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. Gawad
 
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. GawadObesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
 
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadThrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
 
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. GawadAsymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. GawadLupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. GawadInfection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
 
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadInsights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
 
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadDiabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
 
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
 
Hyponatremia (Practical Approach) - Dr. Gawad
Hyponatremia (Practical Approach) - Dr. GawadHyponatremia (Practical Approach) - Dr. Gawad
Hyponatremia (Practical Approach) - Dr. Gawad
 
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
 
Autosomal Dominant Polycystic Kidney Disease (ADPKD) / Emerging Concepts and ...
Autosomal Dominant Polycystic Kidney Disease (ADPKD) / Emerging Concepts and ...Autosomal Dominant Polycystic Kidney Disease (ADPKD) / Emerging Concepts and ...
Autosomal Dominant Polycystic Kidney Disease (ADPKD) / Emerging Concepts and ...
 
AVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. Gawad
AVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. GawadAVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. Gawad
AVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. Gawad
 
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
 

Recently uploaded

Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalorenarwatsonia7
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiNehru place Escorts
 
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000aliya bhat
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipurparulsinha
 
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowKolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowNehru place Escorts
 
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...narwatsonia7
 
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking ModelsMumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking Modelssonalikaur4
 
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersBook Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersnarwatsonia7
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
Call Girls Thane Just Call 9910780858 Get High Class Call Girls Service
Call Girls Thane Just Call 9910780858 Get High Class Call Girls ServiceCall Girls Thane Just Call 9910780858 Get High Class Call Girls Service
Call Girls Thane Just Call 9910780858 Get High Class Call Girls Servicesonalikaur4
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaPooja Gupta
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbaisonalikaur4
 
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...narwatsonia7
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...saminamagar
 
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service LucknowVIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknownarwatsonia7
 
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...narwatsonia7
 

Recently uploaded (20)

Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
 
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
 
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowKolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
 
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
 
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking ModelsMumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
 
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
 
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersBook Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
Call Girls Thane Just Call 9910780858 Get High Class Call Girls Service
Call Girls Thane Just Call 9910780858 Get High Class Call Girls ServiceCall Girls Thane Just Call 9910780858 Get High Class Call Girls Service
Call Girls Thane Just Call 9910780858 Get High Class Call Girls Service
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
 
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
 
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
 
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service LucknowVIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
 
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
 

Uremic Pruritis - Pathogenesis & Management - Dr. Gawad

  • 1. Uremic Pruritus Pathogenesis & Management Mohammed Abdel Gawad Nephrology Specialist Kidney & Urology Center (KUC) Alexandria – EGY drgawad@gmail.com 7th NephroShams / 15-17 Oct 2015
  • 2. Weak Soft Evidence • Small number of patients were tested by different studies. • Conflicting and contradictory results • Short time of follow up • Lack of head-to-head comparisons among different agents 19
  • 3. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 19
  • 4. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 19
  • 5. Hiroshige K. Am J Kidney Dis. 1995 Mar;25(3):413-9. 3 months of observation n=59 19
  • 6. n=111 Ko MJ et al. PLoS One. 2013 Aug 6;8(8):e71404. p = 0.002 18
  • 7. Saudi J Kidney Dis Transpl 2015;26(5):890-895 Significantly higher Kt/V in the patients with pruritus. 18
  • 8. n=105 Duque MI et al. Clin Nephrol 2006; 66:184. 18
  • 9. n=105 • Higher Kt/V = prolonged contact with dialyzer membranes or silicone tubing. • If no residual renal function or worse metabolic parameters = need higher Kt/V Accounted for the pruritus Duque MI et al. Clin Nephrol 2006; 66:184. 18
  • 10. It is suggested to use generally accepted Kt/V targets because of overall benefit conferred rather than a specific demonstrated effect on pruritus 17
  • 11. Ko MJ et al. PLoS One. 2013 Aug 6;8(8):e71404. 17
  • 12. Lin HH et al. Artif Organs. 2008 Jun;32(6):468-72. Started using PMMA P < 0.001 Back to previously used high flux filter 17
  • 13. Lin HH et al. Artif Organs. 2008 Jun;32(6):468-72. Started using PMMA Back to previously used high flux filter P < 0.001 17
  • 14. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 16
  • 15. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 16
  • 16. Pathogenesis Xerosis Decrease in sweat volume Atrophy Dehydration Pornanong Aramwit. Updates in Hemodialysis. Chapter 2. September 9, 2015. 16
  • 17. Topical Moisturing & Emollients Thomas Mettang. Kidney International (2015) 87, 685–691. Manenti et al. Kidney Int, 2008. 73(4): p. 512. It has been suggested by several researchers that the use of emollients with high water content should be the first-line treatment • Dexpanthenol • Glycerol and Paraffin • If simple emollients fail: –Evening Primrose oil rich in essential fatty acids (γ-linolenic acid) –Bath oil that contains polidocanol –Cream that contains natural lipids and endocannabinoids Pornanong Aramwit. Updates in Hemodialysis. Chapter 2. September 9, 2015. 16
  • 18. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 15
  • 19. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 15
  • 20. Pathogenesis – Microinflamation (1) Interleukin 2 Th1 lymphocytes Interleukin 2 Kurban et al. Clin Dermatol, 2008. 26(3): p. 255-264. 15
  • 21. Th1 lymphocytes Interleukin 2 Gianni LM et al. Ann Pharmacother 2001; 35: 943–946. Pauli-Magnus C et al. Perit Dial Int 2000; 6: 802–803. Kuypers DR et al. Nephrol Dial Transplant 2004; 19: 1895–1901. Tacrolimus Ointment 2 times/day for 1-6 weeks 15
  • 22. Th1 lymphocytes Interleukin 2 Gianni LM et al. Ann Pharmacother 2001; 35: 943–946. Pauli-Magnus C et al. Perit Dial Int 2000; 6: 802–803. Kuypers DR et al. Nephrol Dial Transplant 2004; 19: 1895–1901. Tacrolimus Ointment 2 times/day for 1-6 weeks 15
  • 23. Pathogenesis – Microinflamation (2) TNF-α and IL-1β Aramwit et al. J Biosci Bioeng, 2009. 107(5): p. 556-561. 14
  • 24. Sericin Cream (concentration 8%) Water-soluble protein that is obtained from the silkworm (Bombyx mori) Characterized by the presence of 32% serine, which is the main amino acid of the natural moisture factor (NMF) in human skin Pornanong Aramwit. Updates in Hemodialysis. Chapter 2. September 9, 2015. O. Keongamaroon. et al. BMC Nephrol, 2012. 13: p. 119. Twice daily for 6 weeks 14
  • 25. Sericin Cream (concentration 8%) Water-soluble protein that is obtained from the silkworm (Bombyx mori) Pornanong Aramwit. Updates in Hemodialysis. Chapter 2. September 9, 2015. O. Keongamaroon. et al. BMC Nephrol, 2012. 13: p. 119. Twice daily for 6 weeks 14
  • 26. Pathogenesis – Microinflamation (3) TNF-α Zhang R et al. J Immunother 2007; 30: 89–95 Silva SR et al. Nephron 1994; 67: 270–273. TNF α Thalidomide Pentoxifylline 14
  • 27. Pentoxifylline - Pathogenesis The American Journal of Gastroenterology 109, 1424-1426 (September 2014) Anti-inflammatory 13
  • 28. Mettang T et al. Nephrol Dial Transplant 2007; 22: 2727–2728. Pentoxifylline: 600mg IV, 3X/week (at the end of each dialysis session), for 4 weeks n = 7 on HD (didn’t respond to gabapentin or UVB-phototherapy) 3 patients stopped treatment n = 1 Insomnia n = 2 Nausea n = 1 Jaundice Itch score (median; range) 13
  • 29. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 10
  • 30. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 13
  • 31. Pathogenesis – Nervous Conduction (1) Substance P C fibers Tarikci N et al. Scientific World Journal. 2015;2015:803752 Kuypers DR. Nat Clin Pract Nephrol 2009; 5:157. 12
  • 32. Capsaicin 0.025% Cream C fibers Tarng, D.C. et al. Nephron, 1996. 72(4): p. 617-622. Breneman et al. J Am Acad Dermatol, 1992. 26(1): p. 91-94. Cho YL et al. J Am Acad Dermatol 1997; 36:538. Kuypers DR. Nat Clin Pract Nephrol 2009; 5:157. Extract from capsicum or common pepper plant 12
  • 33. Capsaicin 0.025% Cream C fibers Tarng, D.C. et al. Nephron, 1996. 72(4): p. 617-622. Breneman et al. J Am Acad Dermatol, 1992. 26(1): p. 91-94. Cho YL et al. J Am Acad Dermatol 1997; 36:538. Kuypers DR. Nat Clin Pract Nephrol 2009; 5:157. Extract from capsicum or common pepper plant 12 vanilloid receptor subtype 1
  • 34. Capsaicin 0.025% Cream C fibers Tarng, D.C. et al. Nephron, 1996. 72(4): p. 617-622. Breneman et al. J Am Acad Dermatol, 1992. 26(1): p. 91-94. Cho YL et al. J Am Acad Dermatol 1997; 36:538. Kuypers DR. Nat Clin Pract Nephrol 2009; 5:157. Extract from capsicum or common pepper plant 12 vanilloid receptor subtype 1 May not be a practical solution for large areas or generalized pruritus
  • 35. Pathogenesis – Nervous Conduction (2) Ca Channel Thomas Mettang. Kidney International (2015) 87, 685–691. 12
  • 36. Gabapentin / Pregabalin Thomas Mettang. Kidney International (2015) 87, 685–691. 11
  • 37. Razeghi E et al. Ren Fail 2009; 31: 85–90. Gabapentin n = 34 on HD Double-blind, Crossover study 100 mg of oral gabapentin 3X/week Gabapentin therapy phase Washout & Placebo phase 11
  • 38. Gunal AI et al. Nephrol Dial Transplant 2004; 19: 3137–3139. n = 25 on HD 300 mg of oral gabapentin 3X/week for 4 weeks 8.4 1.2 4 weeks Gabapentin 11
  • 39. Gunal AI et al. Nephrol Dial Transplant 2004; 19: 3137–3139. Pregabalin 21 10
  • 40. Gunal AI et al. Nephrol Dial Transplant 2004; 19: 3137–3139. Pregabalin 16 started Pregabalin 21 n = 13 (81%) 10
  • 41. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 10
  • 42. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 10
  • 43. Pathogenesis Opioid Hypothesis Keiichi Niikura et al. Trends in Pharm Science. Volume 31, Issue 7. July 2010, Pages 299–305 10 Pain ↓ Pain Ƙ opioid receptor µ opioid receptor
  • 44. Pathogenesis Opioid Hypothesis Kumagai H et al. In: Itch, Basic Mechanisms and Therapy, New York 2004. p.286. 9 Pain ↓ Pain Ratio of the µ- receptor agonist (beta-endorphin) to Ƙ-receptor agonist (dynorphin-A) is increased in hemodialysis patients µ opioid receptor Ƙ opioid receptor
  • 45. Naltrexone / Nalfurafine Kumagai H et al. In: Itch, Basic Mechanisms and Therapy, New York 2004. p.286. 9 Pain ↓ Pain µ opioid receptor Ƙ opioid receptor Naltrexone µ-antagonist Nalfurafine Ƙ-agonist
  • 46. Naltrexone (µ-antagonist) Peer G et al. Lancet 1996; 348: 1552–1554.14. n = 15 9
  • 47. Kumagai H et al. Nephrol Dial Transplant 2010; 25: 1251–1257. Nalfurafine (Ƙ-agonist) Placebo (n=111) 5 µg (n=144), P = 0.0002 2.5 µg (n=112), P = 0.0001 8
  • 48. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 8
  • 49. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 8
  • 50. Felix Stockenhuber et al. Clinical Science (1990) 79,477-482 8
  • 51. Weisshaar E et al. Exp Dermatol 2004; 13: 298–304. 7
  • 52. Weisshaar E et al. Exp Dermatol 2004; 13: 298–304. Beneficial effect of anti- histamincs probably results from their sleep-inducing side effect 7
  • 53. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-recptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 7
  • 54. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-recptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 7
  • 55. PTH • Persistent uremic pruritus of patients with secondary hyperparathyroidism decreased after parathyroidectomy • Intradermal application of parathormone did not cause a significant skin reaction in humans. • Itching can occur in patients with accepted PTH serum level. Kleeman CR et al. Trans Assoc Am Physicians. 1968;81:203–212. Massry SG et al. N Engl J Med. 1968;279(13):697–700. Ståhle-Bäckdahl M et al. J Intern Med. 1989;225(6):411–415. 7
  • 56. Calcium & Phosphorous • Hypercalcemia and hyperphosphatemia with secondary deposition of calcium phosphate crystals in the skin may contribute to itch. • Calcium × phosphate < 55 can play a role in improving the pruritus. • Pruritus may recur when serum calcium is restored to normal, or persist despite low serum calcium levels. Kurban et al. . Clin Dermatol, 2008. 26(3): p. 255-264. Schwartz, I.F. and A. Iaina, Semin Dial, 2000. 13(3): p. 177-180. 6
  • 57. Chou FF et al. J Am Coll Surg 2000; 190:65. 6
  • 58. Chou FF et al. J Am Coll Surg 2000; 190:65. 6
  • 59. Chou FF et al. J Am Coll Surg 2000; 190:65. 5
  • 60. • Parathyroidectomy should not be considered as a routine therapy for uremic pruritus. • Target the commonly accepted calcium, phosphate and PTH concentrations that have been developed for the overall benefit of such patients. 5
  • 61. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 5
  • 62. PHOTOTHERAPY UVB vs. UVA • Broad band UVB phototherapy reported a marked reduction in pruritus. • Long-wave UVA radiation treatment did not improve itch intensity. • Saltzer et al. Cutis, 1975. 16: p.298-299. • Gilchrest et al. N Engl J Med, 1977. 297(3): p. 136-138 • Gilchrest et al. Ann Intern Med 1979; 91: 17–21. • Gilchrest. Int J Dermatol, 1979. 18(9): p. 741-748. • Blachley et al. Am J Kidney Dis, 1985. 5(5): p.237-241. • Tan JKL et al. J Amer Acad Dermatol 1991; 25: 811–818. • Kurban et al. Clin Dermatol, 2008. 26(3): p. 255-264. 4
  • 63. International Journal of Dermatology. 2007, 46, 367–370 n = 15 5.5  2.7 12  4.1 4
  • 64. M-J. Ko et al. Briish Association of Dermatologists 2011 165, pp633–639 The treatment group received NB-UVB phototherapy three times per week for 6 weeks. The control group received time-matched exposures to long-wave UVA radiation. 4
  • 65. PHOTOTHERAPY High risk for skin malignancies following UVB irradiation Thomas Mettang. Kidney International (2015) 87, 685–691. Other Physical Therapies • Acupuncture • Thermal Therapy • Sauna 3
  • 66. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 3
  • 67. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 3
  • 68. OTHERS • Sertraline • Activated charcoal • Erythropoietin • Omega-3 fatty acid • Turmeric • Zinc • Cholestyramine • Avena sativa • Vinegar • Oral nicotinamide • Pramoxine ointement • IV Lidocaine 3
  • 69. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 2
  • 70. Thomas Mettang. Kidney International (2015) 87, 685–691. 2
  • 71. Thomas Mettang. Kidney International (2015) 87, 685–691. 2 More accurately to be termed ‘chronic kidney disease-associated pruritus’ (CKD-aP)
  • 72. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 2
  • 73. 1 Thomas Mettang. Kidney International (2015) 87, 685–691.
  • 74. Thomas Mettang. Kidney International (2015) 87, 685–691. Modification: M.Gawad www.NephroTubeCNE.com Control Ca, Phosphrous, PTH Pregabalin (25mg after HD to 75 mg daily) if not well tolerated or no response (50 mg daily) !!! Skin cancer 1 Modified approach according to available drugs in Egypt and adding of another drugs with re- arrangement of the drugs sequence
  • 75. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 1
  • 76. Talk Outline • Dialysis adequacy & modification • Xerosis • Microinflamation • Nervous conduction • Opioid hypothesis • Anti-histamine / 5HT3-receptor antagonist • PTH / Calcium / Phosphorus • Physical therapy (UV) • Other therapies • Terminology • Suggested step wise management approach • Is it uremic pruritus? 1
  • 77. Is it uremic pruritus? • Site: most commonly localized to the back, followed by the forearm with an AVF, abdomen, or head. • Most cases presents dry and scaly. • In contrast to dermatological pruritus, primary skin lesions are not observed in patients with CKD-aP. Thomas Mettang. Kidney International (2015) 87, 685–691. 0
  • 78. Is it uremic pruritus? • Site: most commonly localized to the back, followed by the forearm with an AVF, abdomen, or head. • Most cases presents dry and scaly. • In contrast to dermatological pruritus, primary skin lesions are not observed in patients with CKD-aP. Thomas Mettang. Kidney International (2015) 87, 685–691. Scratch marks with excoriations Hyperkeratotic partly excoriated nodules (prurigo nodularis) Deep scars and prurigo nodules 0
  • 79. Is it uremic pruritus? Thomas Mettang. Kidney International (2015) 87, 685–691. • Suspect other etiology if: –More generalized. –Primary specific skin lesions. –Resistant pruritus. Acta Derm Venereol 2012; 92: 563–581 0
  • 80. Thomas Mettang. Kidney International (2015) 87, 685–691. Modification: M.Gawad www.NephroTubeCNE.com Control Ca, Phosphrous, PTH Pregabalin (25mg after HD to 75 mg daily) if not well tolerated or no response (50 mg daily) !!! Skin cancer Exclusion of other causes including drugs if resistant 0 Modified approach according to available drugs in Egypt and adding of another drugs with re- arrangement of the drugs sequence
  • 81. Thomas Mettang. Kidney International (2015) 87, 685–691. Modification: M.Gawad www.NephroTubeCNE.com Control Ca, Phosphrous, PTH Pregabalin (25mg after HD to 75 mg daily) if not well tolerated or no response (50 mg daily) !!! Skin cancer Exclusion of other causes including drugs if resistant 0 Modified approach according to available drugs in Egypt and adding of another drugs with re- arrangement of the drugs sequence